NFAT公司
钙调神经磷酸酶
血管生成
信号转导
细胞生物学
生物
化学
癌症研究
医学
内科学
移植
作者
Andrew Courtwright,Sharareh Siamakpour‐Reihani,Jack L. Arbiser,Natalie Banet,Eleanor Hilliard,Levi Fried,Chad Livasy,David Ketelsen,Desh Bandhu Nepal,Charles M. Perou,Cam Patterson,Nancy Klauber‐DeMore
标识
DOI:10.1158/0008-5472.c.6498726.v1
摘要
<div>Abstract<p>Secreted frizzle-related protein 2 (SFRP2), a modulator of Wnt signaling, has recently been found to be overexpressed in the vasculature of 85% of human breast tumors; however, its role in angiogenesis is unknown. We found that SFRP2 induced angiogenesis in the mouse Matrigel plug assay and the chick chorioallantoic membrane assay. SFRP2 inhibited hypoxia induced endothelial cell apoptosis, increased endothelial cell migration, and induced endothelial tube formation. The canonical Wnt pathway was not affected by SFRP2 in endothelial cells; however, a component of the noncanonical Wnt/Ca<sup>2+</sup> pathway was affected by SFRP2 as shown by an increase in NFATc3 in the nuclear fraction of SFRP2-treated endothelial cells. Tacrolimus, a calcineurin inhibitor that inhibits dephosphorylation of NFAT, inhibited SFRP2-induced endothelial tube formation. Tacrolimus 3 mg/kg/d inhibited the growth of SVR angiosarcoma xenografts in mice by 46% (<i>P</i> = 0.04). In conclusion, SFRP2 is a novel stimulator of angiogenesis that stimulates angiogenesis via a calcineurin/NFAT pathway and may be a favorable target for the inhibition of angiogenesis in solid tumors. [Cancer Res 2009;69(11):4621–8]</p></div>
科研通智能强力驱动
Strongly Powered by AbleSci AI